-

KBRA Releases Monthly CMBS Trend Watch

NEW YORK--(BUSINESS WIRE)--KBRA releases the September 2023 issue of CMBS Trend Watch.

September year-to-date volume totaled $25.8 billion, down 59.2% year-over-year (YoY). But on a quarter-over-quarter (QoQ) basis, issuance performance continues to show improvement with YoY percentage declines for Q1-Q3 2023 trending lower. Q4 issuance could follow the trend, with up to 12 deals announcing through early November, including seven conduits, three single-borrower (SB), one single-family rental (SFR), and one Freddie Mac K-Series deal. However, it is far from a sure bet as the U.S. 10-year Treasury rate hovers at multiyear highs, loan volumes remain suppressed, and loans in the works are slow to close. This has contributed to a number of conduits slated for September and early October pushing out launch dates.

In September, KBRA published pre-sales for five deals ($3.7 billion) including two conduits ($1.6 billion), one Agency ($1.1 billion), one SB ($700 million), and one CRE CLO ($364 million). September’s surveillance activity included a review of the ratings of 791 securities issued in connection with 83 transactions. Of the 791 ratings, 760 were affirmed, 24 were downgraded, and seven were upgraded.

This month’s edition also highlights recent KBRA research publications, which cover various topical issues.

Click here to view the report.

Related Publications

About KBRA
KBRA is a full-service credit rating agency registered in the U.S., the EU, and the UK, and is designated to provide structured finance ratings in Canada. KBRA’s ratings can be used by investors for regulatory capital purposes in multiple jurisdictions.

Contacts

Aryansh Agrawal, Analyst, CMBS Ratings Surveillance
+1 646-731-1381
aryansh.agrawal@kbra.com

Larry Kay, Senior Director, CMBS Ratings Surveillance
+1 646-731-2452
larry.kay@kbra.com

Roy Chun, Senior Managing Director, CMBS Ratings Surveillance
+1 646-731-2376
roy.chun@kbra.com

Business Development Contact

Dan Stallone, Senior Director
+1 646-731-1308
daniel.stallone@kbra.com

KBRA

Details
Headquarters: New York City, New York
CEO: Jim Nadler
Employees: 400+
Organization: PRI

Release Versions

Contacts

Aryansh Agrawal, Analyst, CMBS Ratings Surveillance
+1 646-731-1381
aryansh.agrawal@kbra.com

Larry Kay, Senior Director, CMBS Ratings Surveillance
+1 646-731-2452
larry.kay@kbra.com

Roy Chun, Senior Managing Director, CMBS Ratings Surveillance
+1 646-731-2376
roy.chun@kbra.com

Business Development Contact

Dan Stallone, Senior Director
+1 646-731-1308
daniel.stallone@kbra.com

More News From KBRA

KBRA Assigns Preliminary Ratings to Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2)

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 71 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2). The transaction consists of 1,118 investment property mortgages with an aggregate principal balance of $438.4 million as of the March 1, 2026 cut-off date. The collateral is characterized by a weighted average (WA) original credit score of 770 and moderate borrower equity, with a WA original LTV and WA original CLTV of 73.2%. KBR...

KBRA Assigns Preliminary Ratings to Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to six classes of notes issued by Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1 (collectively “RPM 2026-R1”), an auto loan ABS transaction. RPM 2026-R1 has initial credit enhancement levels of 35.69% for the Class A notes to 2.65% for the Class E-2 notes. Credit enhancement is comprised of overcollateralization, subordination of junior note classes (except for the Class E-2 notes), a ca...

KBRA Releases Research – What’s up, Doc – Medical Professional Mortgages, A New Niche in RMBS?

NEW YORK--(BUSINESS WIRE)--KBRA releases research assessing the characteristics of medical professional mortgage (MPM) loans, with a focus on their potential role as a niche collateral segment within the prime private label residential mortgage-backed securities (RMBS) market. MPMs, often called physician or doctor loans, are specialized prime mortgage programs designed for medical professionals whose early-career financial profiles often include high student debt, limited savings, and reliance...
Back to Newsroom